Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Pembrolizumab + Romidepsin for Lymphoma
Recruiting2 awardsPhase 1 & 2
Houston, Texas
This trial is testing pembrolizumab, an immunotherapy, in combination with romidepsin, a cancer growth inhibitor, to treat participants with peripheral T-cell lymphoma that has come back or does not respond to treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service